In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

The National Cancer Center Japan (NCC) has announced the start of a new clinical trial for an anticancer drug prescreened with tumor-bearing mice, saying the use of such mouse models could ...

This information is based on a press release statement from Celcuity. In other recent news, Celcuity Inc. has announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

Insilico Medicine (“Insilico”), a world-leading artificial intelligence (AI)-driven drug discovery company, today announced a multi-year research and development (R&D) collaboration with Servier, an ...

Scientists have developed a new treatment strategy that could one day save the lives of children affected by aggressive brain ...

DOYLESTOWN, Pa. - Aprea Therapeutics Inc. (NASDAQ:APRE) announced Thursday that its lead cancer drug candidate APR-1051 continues to show promising results in ongoing clinical trials, with patients ...

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...

TOKYO -- Fujifilm Holdings has joined hands with German drugmaker Bayer to develop an immune-based cancer treatment using induced pluripotent stem cells.